Peter S Hendricks,Charles D Nichols
Peter S Hendricks
Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice [0.03%]
对一批迷幻疗法治疗师的调查结果显示个人使用迷幻剂很普遍：这对研究和实践有什么影响？
Jacob S Aday,Zachary Skiles,Noa Eaton et al.
Jacob S Aday et al.
Background: An emerging controversy in psychedelic therapy regards the appropriateness or necessity of psychedelic therapists having personal experience using psychedelics themselves. Although there are a number of potent...
A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression [0.03%]
单次使用裸盖菇素可以持续拯救由青少年慢性束缚压力引起的认知缺陷，在与抑郁症相关的实验大鼠系统中，对突触蛋白基因表达没有长期影响
Meghan Hibicke,Hannah M Kramer,Charles D Nichols
Meghan Hibicke
Introduction: Psilocybin has shown long-lasting antidepressant effects in preclinical and clinical trials, but the mechanisms responsible are unclear. As both passive coping strategies and pattern separation deficits are ...
Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding Strategy [0.03%]
迷幻药物医学的未来取决于积极制定稳健的医疗计费和编码策略
Brian S Barnett,Andrey Ostrovsky
Brian S Barnett
Background: Although still investigational, psychedelic therapies appear poised to begin securing regulatory approval as medical treatments in the United States within the next 2 years. If approved, one of the most daunti...
David E Nichols,Charles D Nichols,Peter S Hendricks
David E Nichols
Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings [0.03%]
针对两名使用丁丙诺啡稳定治疗的成年人使用裸盖菇素治疗阿片类药物使用障碍的技术报告及初步研究结果修改报告
Christopher R Nicholas,David M Horton,Julia Malicki et al.
Christopher R Nicholas et al.
Background: Psilocybin has demonstrated promising clinical outcomes for nicotine and alcohol use disorders, yet its potential clinical utility in the treatment of opioid use disorder (OUD) remains unreported in modern lit...
The Therapeutic Alliance in Psychedelic-Assisted Psychotherapy: A Novel Target for Research and Interventions [0.03%]
迷幻剂辅助心理治疗中的治疗同盟：研究和干预的新目标
Philip Kamilar-Britt,Elana B Gordis,Mitch Earleywine
Philip Kamilar-Britt
Clinical trials support the promise of psychedelic-assisted therapy (PAT) and reveal potential mechanisms underlying efficacy. Out of necessity, initial studies of PAT have focused on feasibility and impact with special attention to acute r...
A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions [0.03%]
迷幻剂临床试验中报告实践的系统回顾：心理支持、疗法和心理社会干预
William Brennan,Alex R Kelman,Alexander B Belser
William Brennan
Background: Psychedelic-assisted therapy has gained significant attention in recent years. However, there is a lack of empirical clarity on the role of psychosocial interventions (PIs) in clinical trials of psychedelic tr...
Kelley C O&#x;Donnell,Daniel E Roberts,Terence H W Ching et al.
Kelley C O&#x;Donnell et al.
Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A Translational Research Agenda [0.03%]
防止迷幻研究中的差距成为实践陷阱的转化研究议程
Andrew Penn,Rachel Yehuda
Andrew Penn
The reemergence of psychedelic medicines as clinical treatments has generated considerable interest in both professional and popular arenas. Although evidence is promising for psychedelic-assisted therapy (PAT), there is much that is not ye...